Remus Pharmaceuticals Ltd Share Price

Biotechnology

NSE: REMUS Small Cap ISIN: INE0O5T01011

As on 31 January 2025 at 13:51 IST

₹2,275

-49.95

(-2.15%)

Sell Buy

Over 1 Month

-3.54%

Over 6 Months

22.09%

Over 1 Year

48.26%

Over 3 Years

Remus Pharmaceuticals Ltd Summary

Close ₹ 2,275

Open ₹ 2,300

High ₹ 2,302

Low ₹ 2,251

Volume 300

Net Turnover (in ₹ Cr) ₹ 0.98

52Wk High ₹ 2,834.75

52Wk Low ₹ 1,200

52Wk High / Low

1,200

2,834.75

Remus Pharmaceuticals Ltd Fundamentals

Key Financial Data

Market Cap (in ₹Cr) ₹ 1,369.86

EPS (TTM) 28.52

Book Value (BV) 139.28

Div. Yield -

P/E (TTM) 81.43

Price/Book Value 16.69

Delivery % 60.47 %

Face Value 10

Key Ratios

PE Ratio 60.42

PB Ratio 12.38

EV to Sales 15.65

PEG Ratio 1.32

ROA 20.03

ROE 33.24

Debt-Equity 0.09

Net Profit Margin 26.49

Operating Profit Margin 37.39

Remus Pharmaceuticals Ltd Financials

Profit and Loss

Consolidated

Standalone

Yearly

Quarterly

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	217.90	-	-	-	-
Total Expenses	186.07	-	-	-	-
Profit Before Tax	31.83	-	-	-	-
Profit After Tax	25.98	-	-	-	-
Operating Profit after Depreciation	32.31	-	-	-	-

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	11.63	-	-	-	-
Total Non Current Assets	47.53	-	-	-	-
Total Current Assets	209.74	-	-	-	-
TOTAL ASSETS	257.27	-	-	-	-
Total Shareholder's Fund	86.86	-	-	-	-

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	3.60	-	-	-	-
Net Cash used in Investing Activities	-8.94	-	-	-	-
Net Cash used in Financing Activities	24.37	-	-	-	-

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	67.19	46.60	25.44	19.22	12.77
Total Expenses	44.67	35.19	20.82	17.82	11.67
Profit Before Tax	22.52	11.41	4.61	1.41	1.09
Profit After Tax	16.82	8.50	3.43	1.06	0.81
Operating Profit after Depreciation	22.84	11.65	4.70	1.44	1.14

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	2.29	2.54	0.31	0.39	0.50
Total Non Current Assets	46.90	23.32	8.17	3.52	0.54
Total Current Assets	51.16	11.34	7.69	7.50	4.76
TOTAL ASSETS	98.05	34.66	15.86	11.02	5.30
Total Shareholder's Fund	82.06	19.14	6.58	3.14	2.02

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	2.43	5.31	5.04	-0.12	1.30
Net Cash used in Investing Activities	-20.90	-15.19	-4.55	-0.13	-0.56
Net Cash used in Financing Activities	39.29	11.77	-0.17	-0.11	0.06

No data available

Remus Pharmaceuticals Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 2,246.68

S2 2,168.42

S3 2,121.73

Pivot 2,293.37

R1 2,371.63

R2 2,418.32

R3 2,496.58

Moving Average

20 SMA 2,251.01

50 SMA 2,404.70

100 SMA 2,472.56

200 SMA 2,260.78

Remus Pharmaceuticals Ltd Corporate Actions

Dividend

Bonus

Splits

Rights

AGM

EGM

Remus Pharmaceuticals Ltd

₹1/Share

Announcement Date 19 Nov 2024

Record Date 20 Nov 2024

Div Yield 10%

Remus Pharmaceuticals Ltd Peer Comparison

Company	Price	Market Cap (in ₹ Cr)
Remus Pharmaceuticals Ltd	₹2,324.95	₹1,369.86
Sun Pharmaceuticals Industries Ltd	₹1,745.25	₹4,18,743.94
Divis Laboratories Ltd	₹5,733.60	₹1,52,209.07
Cipla Ltd	₹1,458.15	₹1,17,762.24
Torrent Pharmaceuticals Ltd	₹3,357.15	₹1,13,616.11
Mankind Pharma Ltd	₹2,488.40	₹1,02,663.15

Remus Pharmaceuticals Ltd News

Board of Remus Pharmaceuticals recommends interim dividend

Of Rs 1 per share

09 Nov 2024, 04:57 pm

Remus Pharmaceuticals to convene board meeting

On 9 November 2024

07 Nov 2024, 10:21 am

Remus Pharmaceuticals to convene AGM

On 20 September 2024

31 Aug 2024, 03:40 pm

Remus Pharmaceuticals to table results

On 16 May 2024

10 May 2024, 12:07 pm

Remus Pharmaceuticals schedules EGM

On 21 May 2024

24 Apr 2024, 10:34 am

Remus Pharmaceuticals Ltd Stock Analysis

Annual revenue for Remus Pharmaceuticals Ltd increased by 44.17% to ₹67.19 crore in FY 2024 from ₹46.60 crore in FY 2023.
Annual Net Profit for Remus Pharmaceuticals Ltd increased by 97.81% to ₹16.82 crore in FY 2024 from ₹8.50 crore in FY 2023.
Promoter Shareholding in Remus Pharmaceuticals Ltd increased by 0.25% in the most recent quarter, from 70.66% in June 2024 to 70.84% in September 2024.
Remus Pharmaceuticals Ltd delivered a 1-year return of 48.26% compared to the Nifty 50, which provided a return of 8.03% as of the last trading session.
Remus Pharmaceuticals Ltd share price moved down by 2.15% from its previous close of INR ₹2,324.95. The latest Remus Pharmaceuticals Ltd share price is INR ₹2,275.
Remus Pharmaceuticals Ltd share price today has been at a low of 2,251 and a high of 2,302. Over the past 52 weeks, the Remus Pharmaceuticals Ltd share price has seen a low of 1,200 and a high of 2,834.75.